お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は泌尿器系薬剤市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは泌尿器系薬剤の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の泌尿器系薬剤市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは泌尿器系薬剤のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に泌尿器系薬剤市場を分類しています。本研究に含まれる主な企業は：Viatris、Pfizer、Merck、Astellas Pharma、Abbott、ADVANZ PHARMA、GlaxoSmithKline、Bayer HealthCare Pharmaceuticals、Novartis、Piramal Pharma Solutions、Endo International、Sanofi-aventis U.S. LLC、AbbVie、Mallinckrodt、Lilly

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Alpha Blockers
    5-Alpha Inhibitors
    Anticholinergics
    Others

用途別の市場セグメント：
    SUI
    BPH
    OAB
    ED
    Prostate Cancer
    Others

本レポートの詳細内容
世界の泌尿器系薬剤市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、泌尿器系薬剤タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の泌尿器系薬剤収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の泌尿器系薬剤市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、泌尿器系薬剤市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

泌尿器系薬剤のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：泌尿器系薬剤のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：泌尿器系薬剤の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章泌尿器系薬剤企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：泌尿器系薬剤の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：泌尿器系薬剤の主要企業の概要を提供し、製品の説明と仕様、泌尿器系薬剤の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Urological Medications are drugs used in the treatment of urogenital conditions and diseases such as SUI,BPH,OAB and ED.

Market Analysis and Insights: Global Urological Medications Market
The global Urological Medications market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Urological Medications market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Urological Medications, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Urological Medications, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Urological Medications revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Urological Medications market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Urological Medications revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
    Viatris
    Pfizer
    Merck
    Astellas Pharma
    Abbott
    ADVANZ PHARMA
    GlaxoSmithKline
    Bayer HealthCare Pharmaceuticals
    Novartis
    Piramal Pharma Solutions
    Endo International
    Sanofi-aventis U.S. LLC
    AbbVie
    Mallinckrodt
    Lilly

Segment by Type
    Alpha Blockers
    5-Alpha Inhibitors
    Anticholinergics
    Others

Segment by Application
    SUI
    BPH
    OAB
    ED
    Prostate Cancer
    Others

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Urological Medications in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Urological Medications companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Urological Medications revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Urological Medications Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Alpha Blockers
    Table 3. Key Players of 5-Alpha Inhibitors
    Table 4. Key Players of Anticholinergics
    Table 5. Key Players of Others
    Table 6. Global Urological Medications Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 7. Global Urological Medications Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Urological Medications Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Urological Medications Market Share by Region (2019-2024)
    Table 10. Global Urological Medications Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Urological Medications Market Share by Region (2025-2030)
    Table 12. Urological Medications Market Trends
    Table 13. Urological Medications Market Drivers
    Table 14. Urological Medications Market Challenges
    Table 15. Urological Medications Market Restraints
    Table 16. Global Urological Medications Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Urological Medications Revenue Share by Players (2019-2024)
    Table 18. Global Top Urological Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urological Medications as of 2023)
    Table 19. Global Urological Medications Industry Ranking 2022 VS 2023 VS 2024
    Table 20. Global 5 Largest Players Market Share by Urological Medications Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Global Key Players of Urological Medications, Headquarters and Area Served
    Table 22. Global Key Players of Urological Medications, Product and Application
    Table 23. Global Key Players of Urological Medications, Product and Application
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Urological Medications Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Urological Medications Revenue Market Share by Type (2019-2024)
    Table 27. Global Urological Medications Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Urological Medications Revenue Market Share by Type (2025-2030)
    Table 29. Global Urological Medications Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Urological Medications Revenue Share by Application (2019-2024)
    Table 31. Global Urological Medications Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Urological Medications Revenue Share by Application (2025-2030)
    Table 33. North America Urological Medications Market Size by Type (2019-2024) & (US$ Million)
    Table 34. North America Urological Medications Market Size by Type (2025-2030) & (US$ Million)
    Table 35. North America Urological Medications Market Size by Application (2019-2024) & (US$ Million)
    Table 36. North America Urological Medications Market Size by Application (2025-2030) & (US$ Million)
    Table 37. North America Urological Medications Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. North America Urological Medications Market Size by Country (2019-2024) & (US$ Million)
    Table 39. North America Urological Medications Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Europe Urological Medications Market Size by Type (2019-2024) & (US$ Million)
    Table 41. Europe Urological Medications Market Size by Type (2025-2030) & (US$ Million)
    Table 42. Europe Urological Medications Market Size by Application (2019-2024) & (US$ Million)
    Table 43. Europe Urological Medications Market Size by Application (2025-2030) & (US$ Million)
    Table 44. Europe Urological Medications Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Europe Urological Medications Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Europe Urological Medications Market Size by Country (2025-2030) & (US$ Million)
    Table 47. China Urological Medications Market Size by Type (2019-2024) & (US$ Million)
    Table 48. China Urological Medications Market Size by Type (2025-2030) & (US$ Million)
    Table 49. China Urological Medications Market Size by Application (2019-2024) & (US$ Million)
    Table 50. China Urological Medications Market Size by Application (2025-2030) & (US$ Million)
    Table 51. Asia Urological Medications Market Size by Type (2019-2024) & (US$ Million)
    Table 52. Asia Urological Medications Market Size by Type (2025-2030) & (US$ Million)
    Table 53. Asia Urological Medications Market Size by Application (2019-2024) & (US$ Million)
    Table 54. Asia Urological Medications Market Size by Application (2025-2030) & (US$ Million)
    Table 55. Asia Urological Medications Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 56. Asia Urological Medications Market Size by Region (2019-2024) & (US$ Million)
    Table 57. Asia Urological Medications Market Size by Region (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Urological Medications Market Size by Type (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Urological Medications Market Size by Type (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Urological Medications Market Size by Application (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Urological Medications Market Size by Application (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Urological Medications Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 63. Middle East, Africa, and Latin America Urological Medications Market Size by Country (2019-2024) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Urological Medications Market Size by Country (2025-2030) & (US$ Million)
    Table 65. Viatris Company Details
    Table 66. Viatris Business Overview
    Table 67. Viatris Urological Medications Product
    Table 68. Viatris Revenue in Urological Medications Business (2019-2024) & (US$ Million)
    Table 69. Viatris Recent Developments
    Table 70. Pfizer Company Details
    Table 71. Pfizer Business Overview
    Table 72. Pfizer Urological Medications Product
    Table 73. Pfizer Revenue in Urological Medications Business (2019-2024) & (US$ Million)
    Table 74. Pfizer Recent Developments
    Table 75. Merck Company Details
    Table 76. Merck Business Overview
    Table 77. Merck Urological Medications Product
    Table 78. Merck Revenue in Urological Medications Business (2019-2024) & (US$ Million)
    Table 79. Merck Recent Developments
    Table 80. Astellas Pharma Company Details
    Table 81. Astellas Pharma Business Overview
    Table 82. Astellas Pharma Urological Medications Product
    Table 83. Astellas Pharma Revenue in Urological Medications Business (2019-2024) & (US$ Million)
    Table 84. Astellas Pharma Recent Developments
    Table 85. Abbott Company Details
    Table 86. Abbott Business Overview
    Table 87. Abbott Urological Medications Product
    Table 88. Abbott Revenue in Urological Medications Business (2019-2024) & (US$ Million)
    Table 89. Abbott Recent Developments
    Table 90. ADVANZ PHARMA Company Details
    Table 91. ADVANZ PHARMA Business Overview
    Table 92. ADVANZ PHARMA Urological Medications Product
    Table 93. ADVANZ PHARMA Revenue in Urological Medications Business (2019-2024) & (US$ Million)
    Table 94. ADVANZ PHARMA Recent Developments
    Table 95. GlaxoSmithKline Company Details
    Table 96. GlaxoSmithKline Business Overview
    Table 97. GlaxoSmithKline Urological Medications Product
    Table 98. GlaxoSmithKline Revenue in Urological Medications Business (2019-2024) & (US$ Million)
    Table 99. GlaxoSmithKline Recent Developments
    Table 100. Bayer HealthCare Pharmaceuticals Company Details
    Table 101. Bayer HealthCare Pharmaceuticals Business Overview
    Table 102. Bayer HealthCare Pharmaceuticals Urological Medications Product
    Table 103. Bayer HealthCare Pharmaceuticals Revenue in Urological Medications Business (2019-2024) & (US$ Million)
    Table 104. Bayer HealthCare Pharmaceuticals Recent Developments
    Table 105. Novartis Company Details
    Table 106. Novartis Business Overview
    Table 107. Novartis Urological Medications Product
    Table 108. Novartis Revenue in Urological Medications Business (2019-2024) & (US$ Million)
    Table 109. Novartis Recent Developments
    Table 110. Piramal Pharma Solutions Company Details
    Table 111. Piramal Pharma Solutions Business Overview
    Table 112. Piramal Pharma Solutions Urological Medications Product
    Table 113. Piramal Pharma Solutions Revenue in Urological Medications Business (2019-2024) & (US$ Million)
    Table 114. Piramal Pharma Solutions Recent Developments
    Table 115. Endo International Company Details
    Table 116. Endo International Business Overview
    Table 117. Endo International Urological Medications Product
    Table 118. Endo International Revenue in Urological Medications Business (2019-2024) & (US$ Million)
    Table 119. Endo International Recent Developments
    Table 120. Sanofi-aventis U.S. LLC Company Details
    Table 121. Sanofi-aventis U.S. LLC Business Overview
    Table 122. Sanofi-aventis U.S. LLC Urological Medications Product
    Table 123. Sanofi-aventis U.S. LLC Revenue in Urological Medications Business (2019-2024) & (US$ Million)
    Table 124. Sanofi-aventis U.S. LLC Recent Developments
    Table 125. AbbVie Company Details
    Table 126. AbbVie Business Overview
    Table 127. AbbVie Urological Medications Product
    Table 128. AbbVie Revenue in Urological Medications Business (2019-2024) & (US$ Million)
    Table 129. AbbVie Recent Developments
    Table 130. Mallinckrodt Company Details
    Table 131. Mallinckrodt Business Overview
    Table 132. Mallinckrodt Urological Medications Product
    Table 133. Mallinckrodt Revenue in Urological Medications Business (2019-2024) & (US$ Million)
    Table 134. Mallinckrodt Recent Developments
    Table 135. Lilly Company Details
    Table 136. Lilly Business Overview
    Table 137. Lilly Urological Medications Product
    Table 138. Lilly Revenue in Urological Medications Business (2019-2024) & (US$ Million)
    Table 139. Lilly Recent Developments
    Table 140. Research Programs/Design for This Report
    Table 141. Key Data Information from Secondary Sources
    Table 142. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Urological Medications Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Urological Medications Market Share by Type: 2023 VS 2030
    Figure 3. Alpha Blockers Features
    Figure 4. 5-Alpha Inhibitors Features
    Figure 5. Anticholinergics Features
    Figure 6. Others Features
    Figure 7. Global Urological Medications Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Urological Medications Market Share by Application: 2023 VS 2030
    Figure 9. SUI Case Studies
    Figure 10. BPH Case Studies
    Figure 11. OAB Case Studies
    Figure 12. ED Case Studies
    Figure 13. Prostate Cancer Case Studies
    Figure 14. Others Case Studies
    Figure 15. Urological Medications Report Years Considered
    Figure 16. Global Urological Medications Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 17. Global Urological Medications Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 18. Global Urological Medications Market Share by Region: 2023 VS 2030
    Figure 19. Global Urological Medications Market Share by Players in 2023
    Figure 20. Global Top Urological Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urological Medications as of 2023)
    Figure 21. The Top 10 and 5 Players Market Share by Urological Medications Revenue in 2023
    Figure 22. North America Urological Medications Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. North America Urological Medications Market Share by Type (2019-2030)
    Figure 24. North America Urological Medications Market Share by Application (2019-2030)
    Figure 25. North America Urological Medications Market Share by Country (2019-2030)
    Figure 26. United States Urological Medications Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Canada Urological Medications Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Europe Urological Medications Market Size YoY (2019-2030) & (US$ Million)
    Figure 29. Europe Urological Medications Market Share by Type (2019-2030)
    Figure 30. Europe Urological Medications Market Share by Application (2019-2030)
    Figure 31. Europe Urological Medications Market Share by Country (2019-2030)
    Figure 32. Germany Urological Medications Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. France Urological Medications Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. U.K. Urological Medications Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Italy Urological Medications Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Russia Urological Medications Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Nordic Countries Urological Medications Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. China Urological Medications Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. China Urological Medications Market Share by Type (2019-2030)
    Figure 40. China Urological Medications Market Share by Application (2019-2030)
    Figure 41. Asia Urological Medications Market Size YoY (2019-2030) & (US$ Million)
    Figure 42. Asia Urological Medications Market Share by Type (2019-2030)
    Figure 43. Asia Urological Medications Market Share by Application (2019-2030)
    Figure 44. Asia Urological Medications Market Share by Region (2019-2030)
    Figure 45. Japan Urological Medications Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. South Korea Urological Medications Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. China Taiwan Urological Medications Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Southeast Asia Urological Medications Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. India Urological Medications Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. Australia Urological Medications Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Middle East, Africa, and Latin America Urological Medications Market Size YoY (2019-2030) & (US$ Million)
    Figure 52. Middle East, Africa, and Latin America Urological Medications Market Share by Type (2019-2030)
    Figure 53. Middle East, Africa, and Latin America Urological Medications Market Share by Application (2019-2030)
    Figure 54. Middle East, Africa, and Latin America Urological Medications Market Share by Country (2019-2030)
    Figure 55. Brazil Urological Medications Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Mexico Urological Medications Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Turkey Urological Medications Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Saudi Arabia Urological Medications Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. Israel Urological Medications Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 60. GCC Countries Urological Medications Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 61. Viatris Revenue Growth Rate in Urological Medications Business (2019-2024)
    Figure 62. Pfizer Revenue Growth Rate in Urological Medications Business (2019-2024)
    Figure 63. Merck Revenue Growth Rate in Urological Medications Business (2019-2024)
    Figure 64. Astellas Pharma Revenue Growth Rate in Urological Medications Business (2019-2024)
    Figure 65. Abbott Revenue Growth Rate in Urological Medications Business (2019-2024)
    Figure 66. ADVANZ PHARMA Revenue Growth Rate in Urological Medications Business (2019-2024)
    Figure 67. GlaxoSmithKline Revenue Growth Rate in Urological Medications Business (2019-2024)
    Figure 68. Bayer HealthCare Pharmaceuticals Revenue Growth Rate in Urological Medications Business (2019-2024)
    Figure 69. Novartis Revenue Growth Rate in Urological Medications Business (2019-2024)
    Figure 70. Piramal Pharma Solutions Revenue Growth Rate in Urological Medications Business (2019-2024)
    Figure 71. Endo International Revenue Growth Rate in Urological Medications Business (2019-2024)
    Figure 72. Sanofi-aventis U.S. LLC Revenue Growth Rate in Urological Medications Business (2019-2024)
    Figure 73. AbbVie Revenue Growth Rate in Urological Medications Business (2019-2024)
    Figure 74. Mallinckrodt Revenue Growth Rate in Urological Medications Business (2019-2024)
    Figure 75. Lilly Revenue Growth Rate in Urological Medications Business (2019-2024)
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed